July 23, 2020

Roche profit, sales slip despite coronavirus test blitz

Zurich (AFP) – Swiss pharmaceutical group Roche, which has been at the forefront of deploying coronavirus tests and research into treatments, said Thursday its first half profit and sales both dipped as consumers put off treatment.The appreciation of the Swiss franc, seen as a safe haven investment during times of trouble, also played a role as both profit and sales rose marginally when changes in exchange rates are stripped out.Net profit slid by 5 percent from the same period last year to 8.5 billion Swiss francs ($9.1 billion, 7.9 billion euros) in the first six months of this year. At cons…

source https://this.kiji.is/en/658945514792584289?c=648607265489716321

Leave a Reply

Your email address will not be published. Required fields are marked *